Yuanji Xu Selected Research

Adenoviridae Infections (Adenovirus Infections)

5/2014

[Expression and activity identification of a fusion protein for promoting adenovirus infection efficiency of dendritic cells].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuanji Xu Research Topics

Disease

22	Neoplasms (Cancer) 04/2024 - 07/2008
15	Nasopharyngeal Carcinoma 07/2023 - 11/2014
7	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2009
5	Esophageal Neoplasms (Esophageal Cancer) 03/2023 - 05/2017
4	Lung Neoplasms (Lung Cancer) 04/2024 - 07/2008
2	Esophageal Squamous Cell Carcinoma 01/2023 - 10/2021
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 01/2017
2	Breast Neoplasms (Breast Cancer) 01/2019 - 01/2015
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2019 - 03/2013
1	Adenocarcinoma of Lung 10/2023
1	Carcinogenesis 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2019
1	Stomach Neoplasms (Stomach Cancer) 01/2019
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 05/2017
1	Osteoarthritis 08/2015
1	Arthritis (Polyarthritis) 08/2015
1	Chronic Hepatitis B 09/2014
1	Hepatitis B 09/2014
1	Adenoviridae Infections (Adenovirus Infections) 05/2014
1	Necrosis 05/2011

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 10/2023 - 07/2008
8	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2019
4	RNA (Ribonucleic Acid)IBA 07/2023 - 01/2021
3	MicroRNAs (MicroRNA)IBA 01/2022 - 05/2020
2	Circular RNAIBA 04/2024 - 01/2021
2	GoldIBA 01/2022 - 05/2017
2	Competitive Endogenous RNAIBA 01/2021 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 05/2020 - 12/2016
2	LigandsIBA 07/2019 - 06/2017
2	NucleosidesIBA 01/2019 - 05/2017
2	Messenger RNA (mRNA)IBA 08/2015 - 02/2009
2	Histone Deacetylase InhibitorsIBA 10/2010 - 07/2008
1	Environmental BiomarkersIBA 07/2023
1	squamous cell carcinoma-related antigenIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	N-methyladenosineIBA 01/2022
1	Aurora Kinase AIBA 01/2022
1	maleimideIBA 01/2022
1	Caspase 3 (Caspase-3)IBA 01/2022
1	6-methyladenineIBA 01/2022
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2022
1	EnzymesIBA 01/2022
1	GlycosaminoglycansIBA 01/2022
1	CytokinesIBA 01/2022
1	Protamine KinaseIBA 01/2022
1	Uric Acid (Urate)IBA 05/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2019
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 01/2019
1	Sincalide FDA Link 11/2018
1	Indicators and Reagents (Reagents)IBA 06/2017
1	Tumor Biomarkers (Tumor Markers)IBA 05/2017
1	Nucleic AcidsIBA 12/2016
1	DeoxyriboseIBA 12/2016
1	Complementary DNA (cDNA)IBA 08/2015
1	Green Fluorescent ProteinsIBA 08/2015
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2015
1	InterferonsIBA 09/2014
1	Interleukin-12 (IL 12)IBA 09/2014
1	DNA VaccinesIBA 01/2014
1	antigen G250IBA 03/2013
1	LuciferasesIBA 01/2013
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2011
1	celastrolIBA 05/2011
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 10/2010
1	Histones (Histone)IBA 10/2010
1	Oncogene Proteins (Oncogene Protein)IBA 03/2010
1	CalciumIBA 08/2008
1	DepsipeptidesIBA 07/2008
1	Thioredoxin-Disulfide ReductaseIBA 07/2008
1	romidepsin (FK228)FDA Link 07/2008

Therapy/Procedure

8	Radiotherapy 01/2022 - 11/2014
4	Immunotherapy 10/2023 - 01/2014
3	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2023 - 11/2014
3	Drug Therapy (Chemotherapy) 01/2023 - 01/2017
3	Therapeutics 01/2022 - 12/2012
2	Induction Chemotherapy 05/2021 - 03/2016
1	Neoadjuvant Therapy 07/2017
1	Gastrostomy 01/2016
1	Chemoradiotherapy 01/2016
1	Brachytherapy 11/2014